¼¼°èÀÇ Ãø¸é È帧 ºÐ¼® ½ÃÀå º¸°í¼­(2025³â)
Lateral Flow Assays Global Market Report 2025
»óǰÄÚµå : 1675934
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,342,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,167,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,992,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ãø¸é È帧 ºÐ¼® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 9.6%ÀÇ ¼ºÀå·ü·Î 178¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº Áúº´ °ËÃâÀÇ ÀÀ¿ë ºÐ¾ß È®´ë, °¡Á¤¿ë Å×½ºÆ® ŰƮÀÇ Ã¤ÅÃ, µ¿¹° Áø´ÜÀÇ È®´ë, ´ÙÁß ºÐ¼®¹ý °³¹ß, ½Äǰ ¹× ȯ°æ °Ë»ç Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¹× ÀçÅà °Ë»ç, Á¦Á¶ ±â¼ú ¹ßÀü, ȯ°æ ¹× ½Äǰ ¾ÈÀü °Ë»ç, ºñ¿ë È¿À²¼º Áß½Ã, ¾à¹° ¹× ¹ÙÀÌ¿À¸¶Ä¿ °ËÃâ¿¡ ´ëÇÑ ÀÀ¿ë µîÀÌ ÀÖ½À´Ï´Ù.

¼¼°èÀûÀ¸·Î Àü¿°º´ÀÇ È®»êÀº Ãø¸é È帧 ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹¿¡¼­´Â HIV ¹× ¸»¶ó¸®¾Æ¿Í °°Àº °¨¿°¼º ÁúȯÀÇ ³ôÀº ¹ß»ý·ü°ú ¿­¾ÇÇÑ ÀÇ·á ½Ã½ºÅÛ ¹× ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Ãø¸é È帧 ºÐ¼® °Ë»çÀÇ Ã¤ÅÃÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÃÖ±Ù Äڷγª19 ÆÒµ¥¹ÍÀº Áúº´ Á¶±â ¹ß°ßÀÇ Çʿ伺À» °­Á¶ÇÏ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 8¿ù ¿µ±¹ ÇàÁ¤±â°üÀÎ UK Health Security Agency°¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, 2023³â ¿µ±¹¿¡¼­ 368°ÇÀÇ È«¿ª ȯÀÚ°¡ º¸°íµÇ¾î 2022³â 53°Çº¸´Ù ¾à 7¹è Áõ°¡ÇßÀ¸¸ç, ¿þ½ºÆ®¹Ìµé·£Áî¿Í ·±´øÀÌ °¢°¢ 44%¿Í 33%¸¦ Â÷ÁöÇß½À´Ï´Ù. °¢°¢ 44%¿Í 33%¸¦ Â÷ÁöÇß½À´Ï´Ù. ±× °á°ú, Àü ¼¼°èÀûÀ¸·Î Àü¿°º´ÀÇ ³ôÀº À¯ÇàÀÌ Ãø¸é È帧 ºÐ¼® ½ÃÀåÀÇ È®´ë¿¡ ±â¿©ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ´çºÐ°£ Ãø¸é È帧 ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸¸¼ºÁúȯÀº Àå±âÀûÀ¸·Î Áö¼ÓµÇ´Â °Ç°­»óÅ·ΠÁö¼ÓÀûÀÎ ÀÇ·áÀû °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. Ãø¸é È帧 ºÐ¼®Àº ¸¸¼º ÁúȯÀÇ ºü¸£°í °£ÆíÇÑ Áø´ÜÀ» À§ÇØ È°¿ëµÇ¸ç, ½Å¼ÓÇÑ ÇöÀå °Ë»ç ¹× ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ½ºÀ§½º¿¡ º»ºÎ¸¦ µÐ À¯¿£ Àü¹®±â±¸ÀÎ ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, 2022³â 9¿ù ±âÁØ Àü ¼¼°èÀûÀ¸·Î ¸Å³â ¾à 4,100¸¸ ¸íÀÌ ºñ°¨¿°¼º Áúȯ(NCDs) ¶Ç´Â ¸¸¼ºÁúȯÀ¸·Î ÀÎÇØ »ç¸ÁÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ±â·ÏµÈ »ç¸ÁÀÚ ¼öÀÇ 74%¸¦ Â÷ÁöÇÕ´Ï´Ù. ±× Áß ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ 1,790¸¸ ¸í, ¾ÏÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ 930¸¸ ¸í, ¸¸¼º È£Èí±â ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ 410¸¸ ¸í, ´ç´¢º´À¸·Î ÀÎÇÑ »ç¸ÁÀÌ 200¸¸ ¸íÀÔ´Ï´Ù. ÀÌó·³ ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡´Â Ãø¸é È帧 ºÐ¼® ½ÃÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Covid¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A lateral flow assay (LFA) consists of four components: a sample pad where the sample is applied, a conjugate pad that combines labeled tags with biorecognition elements, a reaction membrane featuring test and control lines for the interaction between the target antigen and antibody, and an absorbent pad that collects waste.

The primary categories of lateral flow assays include kits and reagents, along with lateral flow readers. Lateral flow readers are instruments designed for reading and analyzing the results obtained from lateral flow tests. Lateral flow assays operate based on techniques such as sandwich assays, competitive assays, and multiplex detection assays. These assays find applications in various fields, including veterinary diagnostics, clinical/point-of-care testing, drug development and quality testing. They are utilized by hospitals and clinics, diagnostic laboratories, home care settings, as well as pharmaceutical and biotechnology companies, among other end users.

The lateral flow assays market research report is one of a series of new reports from The Business Research Company that provides lateral flow assays market statistics, including lateral flow assays industry global market size, regional shares, competitors with a lateral flow assays market share, detailed lateral flow assays market segments, market trends, and opportunities, and any further data you may need to thrive in the lateral flow assays industry. This lateral flow assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lateral flow assays market size has grown strongly in recent years. It will grow from $11.69 billion in 2024 to $12.39 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to diagnostic advancements, rise in infectious diseases, application in pregnancy testing, growth in home healthcare, development of immunochromatography, point-of-care testing expansion.

The lateral flow assays market size is expected to see strong growth in the next few years. It will grow to $17.88 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanding applications in disease detection, adoption in home testing kits, expansion in veterinary diagnostics, development of multiplex assays, rise in food and environmental testing. Major trends in the forecast period include personalized medicine and home testing, advancements in manufacturing techniques, environmental and food safety testing, focus on cost-effectiveness, application in drug and biomarker detection.

The widespread occurrence of infectious diseases worldwide significantly drives the growth of the lateral flow assay market. In developing nations, the high incidence of infectious diseases such as HIV and malaria, coupled with inadequate healthcare systems and increasing public awareness, is expected to boost the adoption of lateral flow assay testing. The recent COVID-19 pandemic has underscored the necessity for early detection of illnesses, likely propelling market growth. For example, in August 2024, data published by the UK Health Security Agency, a UK-based executive agency, indicated that England reported 368 measles cases in 2023, nearly a sevenfold rise from the 53 cases recorded in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Consequently, the high prevalence of infectious diseases globally will contribute to the expansion of the lateral flow assay market.

The increasing prevalence of chronic diseases is poised to drive the growth of the lateral flow assay market in the foreseeable future. Chronic diseases are long-term health conditions that persist over an extended period, often necessitating ongoing medical management. Lateral flow assay is utilized in chronic diseases for rapid and convenient diagnostics, enabling swift on-site testing and monitoring. As of September 2022, according to the World Health Organization, a specialized agency of the United Nations based in Switzerland, approximately 41 million deaths globally each year are attributed to non-communicable diseases (NCDs) or chronic diseases, accounting for 74% of all recorded deaths. These include 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Thus, the escalating prevalence of chronic diseases serves as a driving force for the lateral flow assay market.

Technological advancements are significant trends gaining traction in the lateral flow assays market. Major players in the lateral flow assay market are concentrating on developing innovative testing products to enhance their market position. For example, in February 2022, Abacus Diagnostica, a Finland-based medical device manufacturer, introduced the second generation of COVID-19 testing, the GenomEra SARS-CoV-2 2.0 Assay Kit. This assay is engineered for the rapid qualitative detection of SARS-CoV-2 in respiratory specimens using a multiplex reverse transcriptase polymerase chain reaction (RT-PCR) method.

Leading companies in the lateral flow assay market are focusing on creating versatile products, such as lateral flow readers, to enable on-the-go testing and gain a competitive advantage. A lateral flow reader is a portable device designed for the quick and qualitative analysis of lateral flow assays, delivering efficient results across various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare firm, launched the Lateral Flow Test for Triaging Stroke Patients. This test, named LVOne, is specifically designed to enhance the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that enables paramedics to identify strokes caused by large vessel occlusions (LVO) within 15 minutes. This prompt identification is critical for fast-tracking patients to specialized stroke centers, where timely treatment can significantly improve outcomes and reduce long-term disabilities.

In December 2023, the U.S.-based software company Danaher Corporation successfully acquired Abcam plc for an undisclosed sum. This strategic move was intended to fortify Danaher Corporation's portfolio and market standing, bolstering its position in the life sciences and diagnostics sector. Abcam PLC, headquartered in the UK, is recognized for producing, distributing, and selling protein research tools along with universal lateral flow assay kits.

Major companies operating in the lateral flow assays market include Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMerieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

North America was the largest region in the lateral flow assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in the lateral flow assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lateral flow assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lateral flow assay market consists of the sale of kits, reagents, and assemblies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this lateral flow assay market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lateral Flow Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lateral flow assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lateral flow assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lateral flow assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Lateral Flow Assays Market Characteristics

3. Lateral Flow Assays Market Trends And Strategies

4. Lateral Flow Assays Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Lateral Flow Assays Growth Analysis And Strategic Analysis Framework

6. Lateral Flow Assays Market Segmentation

7. Lateral Flow Assays Market Regional And Country Analysis

8. Asia-Pacific Lateral Flow Assays Market

9. China Lateral Flow Assays Market

10. India Lateral Flow Assays Market

11. Japan Lateral Flow Assays Market

12. Australia Lateral Flow Assays Market

13. Indonesia Lateral Flow Assays Market

14. South Korea Lateral Flow Assays Market

15. Western Europe Lateral Flow Assays Market

16. UK Lateral Flow Assays Market

17. Germany Lateral Flow Assays Market

18. France Lateral Flow Assays Market

19. Italy Lateral Flow Assays Market

20. Spain Lateral Flow Assays Market

21. Eastern Europe Lateral Flow Assays Market

22. Russia Lateral Flow Assays Market

23. North America Lateral Flow Assays Market

24. USA Lateral Flow Assays Market

25. Canada Lateral Flow Assays Market

26. South America Lateral Flow Assays Market

27. Brazil Lateral Flow Assays Market

28. Middle East Lateral Flow Assays Market

29. Africa Lateral Flow Assays Market

30. Lateral Flow Assays Market Competitive Landscape And Company Profiles

31. Lateral Flow Assays Market Other Major And Innovative Companies

32. Global Lateral Flow Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lateral Flow Assays Market

34. Recent Developments In The Lateral Flow Assays Market

35. Lateral Flow Assays Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â